Delivery Order SPE2DB20D3101-SPE2DB22FH9V8

Award Date 3/3/22
Potential Completion Date 3/4/22
Potential Value $2.3K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a pharmaceutical distribution company, by the Defense Logistics Agency (DLA) for the delivery of BREVIBLOC 2,500 MG/250 ML BAG 250ML pharmaceutical products. The contract has a ceiling value of $2,520.93 and an ultimate completion date of November 13, 2023. This appears to be a delivery order contract with a firm fixed price pricing type. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,156.27, is for the delivery of BREVIBLOC 2,500 MG/250 ML BAG 250ML medical supplies. The contract is a Firm Fixed Price Delivery Order that runs through April 4, 2025. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award, valued at $5,057.73, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division. The award is for the delivery of BREVIBLOC 2,000 MG/100 ML BAG 100ML, a pharmaceutical product, with a performance period through July 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025....
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $3,935.22 from the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of BRIDION 200 MG/2 ML VIAL 2ML, a pharmaceutical product, with a period of performance through April 24, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $2,799.33 for pharmaceutical products and medical supplies. The contract was awarded by the Defense Logistics Agency (DLA) and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $10,535.32 for the supply of various pharmaceutical products and medical supplies. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD), and has an ultimate completion date of June 28, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,486.12 contract is a delivery order under the company's $999,999,999 Indefinite Delivery Contract (IDC) with DLA, which serves as the primary vehicle for Amerisourcebergen to provide a wide range of medical commodities to support military healthcare programs globally....
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order (SPE2DB20D2104|SPE2DB24FT00S) valued at $1,182.71 for pharmaceutical products. The contract was awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of April 2, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as the primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $4,481.50 issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the provision of pharmaceutical products and medical supplies to support military healthcare programs. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $3,591.28 for pharmaceutical and medical supplies to support the Defense Logistics Agency (DLA) Troop Support Medical program. The contract has a performance period through May 18, 2021 and is a firm fixed-price contract type. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00, which...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB22FH9V8
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $2,276.42 for the supply of BREVIBLOC 2,500 MG/250 ML BAG 250ML. The contract, awarded by the Defense Logistics Agency (DLA), has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This delivery order is part of that larger IDC contract, enabling the DLA to efficiently procure essential healthcare commodities for military and veteran healthcare needs.

Generated 2/27/25, 1:29 PM